Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,192.23 16.26 0.51%
FTSE 100 6,702.17 27.43 0.41%
DAX 9,590.68 46.49 0.49%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,544.78 35.14 0.16%

Novo Nordisk A/S: Novo Nordisk increased operating profit by 32% in 2012


Novo Nordisk A/S: Novo Nordisk increased operating profit by 32% in 2012

BAGSVAERD, DENMARK -- (Marketwire) -- 01/31/13 -- Sales growth of 18% driven by Victoza(R), NovoRapid(R) and Levemir(R) Sales increased by 18% to 78.0 billion in Danish kroner and by 12% in local currencies.

* Sales of modern insulins increased by 21% (15% in local currencies).

* Sales of Victoza(R) increased by 58% (50% in local currencies).

* Sales in North America increased by 29% (19% in local currencies).

* Sales in International Operations increased by 18% (16% in local currencies).

Reported operating profit increased by 32% to DKK 29.5 billion including a 1.7 percentage points improvement in the gross margin. Measured in local currencies, operating profit increased by 20%.

Company announcement No 8 / 2013: http://hugin.info/2013/R/1674355/545183.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1674355]

CONTACTS FOR FURTHER INFORMATION Media: Mike Rulis +45 4442 3573 mike@novonordisk.com

Ken Inchausti (US) +1 609 514 8316 kiau@novonordisk.com

Investors: Kasper Roseeuw Poulsen +45 4442 4303 krop@novonordisk.com

Frank Daniel Mersebach +45 4442 0604 fdni@novonordisk.com

Lars Borup Jacobsen +45 3075 3479 lbpj@novonordisk.com

Jannick Lindegaard (US) +1 609 786 4575 jlis@novonordisk.com

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement